You are here: Industry Insights > Cancer

News List

Odds of Developing C. Diff Increased in Older Cancer Patients drugs
August 22, 2019
Older adults with cancer have increased odds of developing Clostridiodes difficile infection (CDI), according to a study published in the September issue of Emerging Infectious Diseases...
Lipophilic Statins May Cut Liver Cancer in Chronic Viral Hepatitis drugs
August 21, 2019
Lipophilic statin use is associated with significantly reduced hepatocellular carcinoma (HCC) incidence and mortality in adults with chronic viral hepatitis...
Minority, Low-Income Individuals Less Likely to Receive Oral Cancer Screening drugs
August 21, 2019
Despite a recent dental visit, more individuals of a minority race/ethnicity and low socioeconomic status report not receiving an oral cancer screening exam...
U.S. Task Force Updates Breast Cancer Gene Testing Recommendations drugs
August 21, 2019
Mutations in two genes -- BRCA1 and BRCA2 -- are known to significantly increase the risk of breast cancer, but experts have long debated which women should be tested for them.
DAAs Cut Deaths in Those Treated for HCV-Related Liver Cancer drugs
August 21, 2019
Among patients with hepatitis C virus (HCV) infection and complete response to hepatocellular carcinoma (HCC) treatment, direct-acting antiviral (DAA) therapy is associated with a significant reduction in the risk for death...
Study finds lack of racial diversity in cancer drug clinical trials worldpharmanews
August 20, 2019
New research published in JAMA Oncology has found a lack of racial and ethnic diversity in clinical trials for cancer drugs. The study - conducted by researchers from UBC, the University of Texas MD Anderson Cancer Center...
FDA grants Rozlytrek cancer treatment approval drugs
August 19, 2019
The cancer therapeutic, Rozlytrek, has gained FDA approval as well as Priority Review, Breakthrough Therapy and Orphan Drug Designations.
Half of Physician Directors of NCI Cancer Centers Receive Industry Payments drugs
August 16, 2019
In 2017, about half of physician directors of National Cancer Institute (NCI)-designated cancer centers received industry payments, according to a research letter published online in JAMA Internal Medicine.
New drug shows encouraging survival in pancreatic cancer worldpharmanews
August 16, 2019
A clinical trial testing a new drug in pancreatic cancer had promising initial results, report researchers from the University of Michigan Rogel Cancer Center.
Lynparza Phase III PAOLA-1 trial met primary endpoint as 1st-line maintenance treatment with bevacizumab for advanced ovarian cancer worldpharmanews
August 16, 2019
AstraZeneca and MSD Inc., Kenilworth, N.J., US (MSD: known as Merck & Co., Inc. inside the US and Canada) announced positive results from the Phase III PAOLA-1 trial in women with advanced ovarian cancer.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 87 88 Next page